Molecular pathways in the development of HPV-induced oropharyngeal cancer

Cell Commun Signal. 2023 Dec 14;21(1):351. doi: 10.1186/s12964-023-01365-0.

Abstract

Oropharyngeal cancer, a subset of head and neck cancer, is increasingly recognized as a unique clinical entity primarily influenced by high-risk human papillomavirus (HPV) infections, particularly HPV-16. This review delves into the viral life cycle of HPV-16 and its interactions with host cells, with a specific focus on the crucial roles played by the viral oncoproteins E6 and E7. These oncoproteins drive cellular proliferation by targeting critical tumor suppressor proteins like p53 and Rb, resulting in uncontrolled cell growth and genomic instability. Furthermore, the significance of epigenetic modifications induced by HPV-16 and their implications is important for cancer progression. This comprehensive review provides valuable insights into the intricate molecular landscape of HPV-induced oropharyngeal cancer, shedding light on the development of targeted therapies and preventive strategies for this emerging global health concern. Video Abstract.

Keywords: Carcinogenesis; HPV; Molecular Pathways; Oncoproteins; Oropharyngeal Cancer.

Publication types

  • Video-Audio Media

MeSH terms

  • Head and Neck Neoplasms*
  • Human papillomavirus 16 / genetics
  • Human papillomavirus 16 / metabolism
  • Humans
  • Oncogene Proteins, Viral* / metabolism
  • Oropharyngeal Neoplasms* / pathology
  • Papillomavirus E7 Proteins / genetics
  • Papillomavirus Infections* / complications
  • Papillomavirus Infections* / genetics
  • Papillomavirus Infections* / pathology

Substances

  • Oncogene Proteins, Viral
  • Papillomavirus E7 Proteins